Adagio Medical Holdings, Inc.

For the period ended Dec 31, 2024. Filed Mar 27, 2025.

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2024 · Filed Mar 27, 2025

ADGM$1.84-4.2%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Consolidated Statements of Operations Consolidated Statements of Comprehensive Loss

Consolidated Statements of Operations and Comprehensive Loss

(in thousands, except share and per share data)


	Years Ended December 31
· · 2024 · · 2023
· · Successor · · · Predecessor · · Predecessor
· · July 31 to December 31 · · · January 1 to July 30 · · January 1 to December 31
Revenue		$269	$333	$300
Cost of revenue and operating expenses:
Cost of revenue		1,937	1,381	1,306
Research and development		4,634	7,585	15,399
Selling, general, and administrative		6,976	13,047	11,537
Impairment - Goodwill		30,324	—	—
Impairment - Intangible assets, net		18,878	—	—
Total cost of revenue and operating expenses		62,749	22,013	28,242
Loss from operations		(62,480)	(21,680)	(27,942)
Other income (expense):
Convertible notes fair value adjustment		929	2,059	(6,930)
Warrant liabilities fair value adjustment		6,576	191	(42)
Interest expense		(1,105)	(1,818)	(1,659)
Interest income		420	3	3
Other (expense) income, net		1,897	(33)	(20)
Total other income (expense), net		8,717	402	(8,648)
Net loss		$(53,763)	$(21,278)	$(36,590)
Other comprehensive loss:
Foreign currency translation adjustment		1	3	(11)
Comprehensive loss		$(53,762)	$(21,275)	$(36,601)

Basic net loss per share (Note 15)		$(3.38)	$(26.08)	$(48.16)
Diluted net loss per share (Note 15)		$(3.70)	$(26.08)	$(48.16)

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.